Is healthcare any good for patients

Slides:



Advertisements
Similar presentations
Comparing different treatments How can we decide?.
Advertisements

Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Economic evaluations alongside clinical trials: what they contribute, how they are performed and their limitations Dr. Stavros Petrou Presentation to Nottingham.
Definitions Patient Experience Patient experience at NUH results from a range of activities that all impact upon patient care, access, safety and outcomes.
1 Could there be a single European EQ tariff? Jan J.V. Busschbach, Ph.D. Former address: –iMTA, Erasmus university Present address: –Medical Psychology.
COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.
Work Disability, Work, and Justification Bias in Europe and the US Arie Kapteyn (RAND) James P. Smith (RAND) Arthur van Soest (Netspar, Tilburg University)
Big Q and Little Q revisited Christopher McCabe PhD Capital Health Endowed Research Chair in Emergency Medicine Research.
Using a discrete choice experiment with duration to estimate values for health states on the QALY scale Nick Bansback Assistant Professor School of Population.
Outcomes that matter to patients: Patient Reported Outcome Measures (PROMs) for people with renal replacement UK Renal Registry 2015 Annual Audit Meeting.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
Measuring benefits Morris et al (2012) Ch Measuring benefits To perform an economic evaluation, we need to have information of the benefits and.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
Measuring the “Q” in QALYs for cost- effectiveness analysis: the EuroQol Group’s approach Valuing health outcomes for healthcare decision making using.
Page 1 Recording of this session via any media type is strictly prohibited. ACA Impact on Workers’ Compensation.
Overview of the EQ-5D Purpose and origins of the descriptive system.
Is healthcare any good for patients? Measuring health outcomes using EQ-5D Professor Paul Kind Principal Investigator Outcomes Research Group Centre for.
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
EQ-5D AND QUALITY OF LIFE OF OSTEOPOROSIS AT-RISK PATIENTS IN A SWEDISH OSTEOPOROSIS PATIENT REGISTRY Arun Krishna 1, Dan Mellström 2, Zhiyi Li 3, Chun-Po.
1 Patient values or values from the general public.
1 The valuation of disease-specific health states to facilitate economic evaluation E. Kok, E. Stolk, Jan J. v. Busschbach Address: –Jan v. Busschbach.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Governance and Public Policy: a NICE example John Brazier Professor of Health Economics, ScHARR, University of Sheffield, UK With thanks to Matt Stevenson.
The third international stroke trial (IST-3) effect of thrombolysis on outcomes at 18 months in 2348 patients in long-term follow- up cohort The IST3 collaborative.
Nuclear and Plasma Science Society IEEE MEMBERSHIP DATA YEARLY CHANGE – SEP 05 l Higher grade … US = 185K -1.8% non US = 97K -1.1% Students…. US = 26K.
1 Health outcome valuation study in Thailand Sirinart Tongsiri Research degree student Health Services Research Unit, Public Health & Policy Department.
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Who is involved in making NICE guidance recommendations and what evidence do they look at? Heidi Livingstone, Senior Public Involvement Adviser.
Working with People with Learning Disabilities Directed Enhanced Service (DES) – Learning Disabilities 2008/09 Appendix 5.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
Patient-reported Outcome Functional Status Assessment (PRO FSA) Heart Failure Measure Testing Project 1.
School of Allied Health Professions & School of Medicine, Health Policy & Practice LAMP A pragmatic unblinded randomised controlled trial and economic.
Canadian TTO Valuations of the EQ-5D-5L: East versus West Differences
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Table 1. Characteristics of generic HRQOL assessments in adult physical activity research Peter D. Hart et al. Systematic Review of Health-Related Quality.
1© GfK 2016 | Concerns about safety and security Concerns about safety and security Global GfK survey July 2016.
1 Utilization of Quality of Life Research in Decision-Making and Policy  Prof. Dr. Jan J.V. Busschbach  Erasmus MC, Rotterdam, The Netherlands  Section.
The burden of disease in patients with personality disorder indicated for psychotherapy: Arguments for necessity of care Djøra Soeteman, MSc
Professor Nancy J. Devlin Office of Health Economics Royal Statistical Society June 18 th 2015 Measuring and ‘valuing’ patient reported health.
NSO data collections of subjective well-being
Dr Dylan Harris Dr Mel Jefferson
Professor Nancy Devlin Director of Research OHE
M. Dakoutrou, V. Gerovasili, G. Sidiras, I. Patsaki, A. Kouvarakos, S
Patient Baseline Assessment
Prof. Dr. Jan J.V. Busschbach
ALLPPT.com _ Free PowerPoint Templates, Diagrams and Charts
Social Norms and Education for English Language Learners
Effect of framing of death on health state values obtained from DCEs
The valuation of disease-specific questionnaires for QALY analysis
Status of EQ-5D-5L Valuation Using Standardized Valuation Methodology
Health Related Issues Source: Odd Stuff Magazine.
Private Healthcare Australia Conference
Analysis of Statistical Units Delineated by OECD Member Countries
Ethics in Research.
Clinical Presentation
Niek Klazinga, Trnava, Thursday
Measuring benefits Morris et al (2012) Ch
Student Champions Learning about NICE
Impact of Mode and Order of Administration on Generic HRQOL Scores
Measuring outcomes Emma Frew October 2012.
Psychiatric comorbidities in adult survivors of major trauma:
How to Measure Quality of Life
Presentation transcript:

Is healthcare any good for patients Is healthcare any good for patients? Measuring health outcomes using EQ-5D Professor Paul Kind Principal Investigator Outcomes Research Group Centre for Health Economics University of York England

Health care Designed / delivered with the intention of altering the “natural” health status of patients over time Relieving pain, suffering Prolonging (enabling) life Easing process of dying Cure (sometimes)

Hippocratic Oath : First, do no harm Fundamental question : how do you know if you are helping / harming the patient ? You need to know does treatment CHANGE anything ? what is the DIRECTION of change ? what is the MAGNITUDE of change ?

Health care intervention Symptomatic relief, cure, palliation ? Yes Problem

Measuring health outcomes the biomedical model (a) [ FEV1 ]t0 - [ FEV1 ]t1  FEV1 (b) [ health]t0 - [ health ]t1  health status there is a calibrated test procedure for (a) what do we use for (b) ?

Outcome measures 'Classical' indicators Survival rates Readmission rates Symptom counts Employment status Days lost through sickness Clinical parameters

Grading angina severity New York Heart Association Grade I ordinary physical activity does not cause undue fatigue, palpitation or anginal pain Grade II comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnoea or anginal pain Grade III comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnoea or anginal pain Grade IV inability to carry on physical activity without discomfort. Symptoms of cardiovascular insufficiency or the anginal syndrome may be present even at rest

Karnofsky Performance Scale

FACT-L

Health-related quality of life a specialised measure of outcome What are the health outcomes ? EQ-5D Health-related quality of life

The EuroQoL Group Set up in 1987 by a multidisciplinary group of researchers concerned with EVALUATION in health and health care Clinicians Health economists Others (sociology, psychology …)

The EuroQoL Group Extended network Founders Finland Netherlands (Norway) Sweden UK Extended network Argentina Canada China Denmark Germany Greece Hungary Italy Japan Korea New Zealand Portugal Russia Slovenia Spain Taiwan USA . . . . Poland ?

So .. what is EQ-5D ? A generic measure of health status (health-related quality of life) capable of being represented as a single index Health is defined in terms of 5 dimensions mobility self care usual activity pain / discomfort anxiety / depression Each dimension is divided into 3 levels none some extreme

What is EQ-5D ? Health state A generic, single index measure of health status Based on 5 dimensions Mobility Self-Care Usual Activity Pain / Discomfort Anxiety / Depression Defines a total of 35 = 243 health states Mobility Self-Care Usual Activity Pain / Discomfort Anxiety / Depression Health state

State 12212 Self-care Pain / discomfort Mobility Health state Usual Anxiety / depression Health state Usual activities For example : no problems in walking about (1) some problems washing self (2) some problems with usual activity (2) no pain or discomfort (1) moderately anxiety or depression (2) State 12212

There is a logical ordinal relationship between some states In general we know NOTHING about the order or values of EQ-5D health states There is a logical ordinal relationship between some states For example 11111 is logically better than 33333 But what is the distance between these states ?

Does moving from state A to state B constitute a patient benefit Does moving from state A to state B constitute a patient benefit ? If so, then by how much? Profile A : 1 1 2 2 3 Profile B : 1 1 3 2 2

Shared objective : Valuing health Needed a simple method Self-administered Capable of being used in population surveys Relatively quick Able to produce cardinal values

Valuation method(s) EuroQoL Group standard Individual experimentation Visual analogue scale rating using a vertical 20cm scale Range 0 – 100 corresponding to “worst imaginable” and “best imaginable” health Individual experimentation Time Trade-Off (York MVH Project) Ranking Paired comparisons Standard Gamble

VAS rating of EQ-5D health states Health state E Health state F 3 3 3 3 3 Health state H VAS rating of EQ-5D health states Health state A Health state C 1 1 1 1 1 Health state D

Profile A : 1 1 2 2 3 Profile B : 1 1 3 2 2 Population preference weights Profile B : 1 1 3 2 2

     MOBILITY I have no problems in walking about    MOBILITY   I have no problems in walking about  I have some problems in walking about  I am confined to bed   ·       For each group of statements please indicate the one that best describes your health today ·   Please tick one box for each group of statements. SELF-CARE   I have no problems with self-care  I have some problems washing or dressing myself  I am unable to wash or dress myself   USUAL ACTIVITIES   I have no problems with performing my usual activities  (e.g. work, study, housework, family or leisure activities) I have some problems with performing my usual activities  I am unable to perform my usual activities   PAIN / DISCOMFORT   I have no pain or discomfort  I have moderate pain or discomfort  I have extreme pain or discomfort     ANXIETY / DEPRESSION  I am not anxious or depressed  I am moderately anxious or depressed  I am extremely anxious or depressed    

TThink about how good or bad your own health is today     TThink about how good or bad your own health is today    This scale may help. The best health you can imagine is marked 100 and the worst health you can imagine is marked 0   Please write in the box below, the number between 0 and 100 that you feel best shows how good your health is today 100 Worst imaginable health Best imaginable health 10 60 50 40 30 20 90 80 70 Your own health today    

Page 3 : Patient Perspective

Page 2 : Societal Perspective MOBILITY I have no problems in walking about I have some problems in walking about I am confined to bed SELF-CARE I have no problems with self-care I have some problems washing or dressing myself I am unable to wash or dress myself USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities) I have no problems with performing my usual activities I have some problems with performing my usual activities I am unable to perform my usual activities PAIN/DISCOMFORT I have no pain or discomfort I have moderate pain or discomfort I have extreme pain or discomfort ANXIETY/DEPRESSION I am not anxious or depressed I am moderately anxious or depressed I am extremely anxious or depressed ? MOBILITY I have no problems in walking about I have some problems in walking about I am confined to bed SELF-CARE I have no problems with self-care I have some problems washing or dressing myself I am unable to wash or dress myself USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities) I have no problems with performing my usual activities I have some problems with performing my usual activities I am unable to perform my usual activities PAIN/DISCOMFORT I have no pain or discomfort I have moderate pain or discomfort I have extreme pain or discomfort ANXIETY/DEPRESSION I am not anxious or depressed I am moderately anxious or depressed I am extremely anxious or depressed

How are EQ-5D data presented ? As a profile based on reported level of problem on each dimension As a health state As a weighted index based on values of the general public As self-rated health status EQ-5D profile health state weighted index self-rated health status Part I Part II

Some examples

Frequency of reported problems by age group in UK population Older age groupsshow more problems Mobiltiy and oain and discomfort are sources of problems 40

Population “norms” mean EQ-5Dindex Source : Health Survey for England, 1996

EQ-5Dindex by age / smoking behaviour 45

EQ-5D for GP clinic attenders

Primary care clinic attendees EQ-5D profile by diagnostic group 59

Rheumatoid arthritis Functional Class I .. complete functional capacity ability to carry out all normal activities II .. adequate for normal activities despite discomfort or limited motion at 1 or more joints III .. limited functional capacity only little or none of duties of normal occupation or selfcare IV .. incapacitated largely or wholly bed-ridden or confined to wheelchair; little or no selfcare

EQ-5Dindex by Functional Class rheumatoid arthritis patients

EQ-5D in treatment of HIV/AIDS

Where are we now ? Science Likely to increase number of response levels from 3 to 5 Investigating a “child-friendly” version of EQ-5D Computer-based valuation and self-assessment methods Electronic data capture – web based technologies

5-level or 3-level ? One suggested modification to existing 3-level descriptive system Place unmarked level between existing levels

Where are we now ? Application Nearly 100 language versions available Worldwide take-up with many normative population studies Widespread incorporation in clinical studies that involve economic evaluation Major head:head study in US of the leading generic HrQoL measures

ends Paul Kind : pk1@york.ac.uk EuroQoL Group : http://www.euroqol.org